Central Venous Catheters - Medical Devices Pipeline Assessment, 2018

Central Venous Catheters - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0602EPD
  • |
  • Pages: 82
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Central Venous Catheters-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Central Venous Catheters-Medical Devices Pipeline Assessment, 2018 provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Central Venous Catheters under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Central Venous Catheters under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Central Venous Catheters Overview 6

3 Products under Development 7

3.1 Central Venous Catheters-Pipeline Products by Stage of Development 7

3.2 Central Venous Catheters-Pipeline Products by Segment 8

3.3 Central Venous Catheters-Pipeline Products by Territory 9

3.4 Central Venous Catheters-Pipeline Products by Regulatory Path 10

3.5 Central Venous Catheters-Pipeline Products by Estimated Approval Date 11

4 Central Venous Catheters-Pipeline Products under Development by Companies 12

4.1 Central Venous Catheters Companies-Pipeline Products by Stage of Development 12

4.2 Central Venous Catheters-Pipeline Products by Stage of Development 13

5 Central Venous Catheters Companies and Product Overview 14

5.1 Ash Access Technology Inc Company Overview 14

5.2 Bactiguard Holding AB Company Overview 15

5.3 Charite University Hospital of Berlin Company Overview 16

5.4 Globe Medical Tech Inc (Inactive) Company Overview 17

5.5 Infusense Corp Company Overview 18

5.6 Marvao Medical Devices Ltd Company Overview 19

5.7 Nipro Corp Company Overview 20

5.8 Pavmed Inc Company Overview 21

5.9 Protectus Medical Devices, Inc. Company Overview 22

5.10 S3V Vascular Technologies Company Overview 23

5.11 Sharklet Technologies Inc Company Overview 24

5.12 Silmag SA Company Overview 25

5.13 Silver Bullet Therapeutics, Inc. Company Overview 27

5.14 Teleflex Inc Company Overview 28

5.15 University of Illinois at Chicago Company Overview 29

5.16 University of Utah Company Overview 30

5.17 Vindica Therapeutics, Inc Company Overview 31

6 Central Venous Catheters- Recent Developments 32

6.1 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 32

6.2 May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 32

6.3 May 15, 2018: B. Braun Brings Its Commitment to The Safe Handling of Hazardous Drugs to ONS 2018 34

6.4 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4% 35

6.5 May 11, 2018: BioCardia Reports First Quarter 2018 Financial Results And Business Highlights 36

6.6 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 36

6.7 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 37

6.8 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 38

6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results 40

6.10 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles 42

6.11 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 43

6.12 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 44

6.13 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017 44

6.14 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 45

6.15 Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results 47

6.16 Mar 07, 2018: Bactiguard launches line extension to BIP CVC 48

6.17 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 48

6.18 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production 49

6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 49

6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 52

6.21 Feb 12, 2018: Region Skane extends agreement with Bactiguard 52

6.22 Feb 06, 2018: BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard 53

6.23 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN 54

6.24 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 55

6.25 Dec 15, 2017: B. Braun Launches Introcan Safety Deep Access IV Catheters 56

6.26 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 56

6.27 Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 57

6.28 Nov 14, 2017: Retractable Technologies Announces Results as of September 30, 2017 59

6.29 Nov 14, 2017: Inserting And Removing Central Venous Catheters Cause Significant Discomfort In Cancer Patients And At Times Is Unnecessary 60

6.30 Nov 13, 2017: i360medical partners with Baptist Hospital South Florida to Launch Innovation Institute Miami 60

6.31 Nov 10, 2017: New clinical study shows fewer adverse events with Bactiguard's central venous catheter compared to a standard central venous catheter 61

6.32 Nov 10, 2017: BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights 62

6.33 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results 62

6.34 Nov 07, 2017: Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer 63

6.35 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 64

6.36 Oct 12, 2017: CAPS to Showcase Latest 503B Quality Assurance Capabilities and Expansion Plans at Health Connect Reverse Expo-Fall Hospital Pharmacy Conference 66

6.37 Oct 04, 2017: Bactiguard's Central Venous Catheters Approved in Hong Kong 66

6.38 Aug 30, 2017: Bactiguard's Central Venous Catheters Approved in India 67

6.39 Aug 23, 2017: Teleflex Awarded Group Purchasing Contract with Vizient for Non-Tunneled Central Venous Catheters 67

6.40 Aug 18, 2017: District Court Issues Final Judgment-Retractable Technologies v. Becton, Dickinson 68

6.41 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 68

6.42 Aug 14, 2017: Retractable Technologies Reports Results as of June 30, 2017 70

6.43 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 71

6.44 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 72

6.45 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 73

6.46 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 75

6.47 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 75

6.48 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology 76

6.49 Jun 14, 2017: i360medical Announces Ray Cantwell as Chairman of the Board 77

7 Appendix 78

7.1 Methodology 78

7.2 About GlobalData 81

7.3 Contact Us 81

7.4 Disclaimer 81

1.2 List of Figures

Figure 1: Central Venous Catheters-Pipeline Products by Stage of Development 8

Figure 2: Central Venous Catheters-Pipeline Products by Segment 9

Figure 3: Central Venous Catheters-Pipeline Products by Territory 10

Figure 4: Central Venous Catheters-Pipeline Products by Regulatory Path 11

Figure 5: Central Venous Catheters-Pipeline Products by Estimated Approval Date 12

1.1 List of Tables

Table 1: Central Venous Catheters-Pipeline Products by Stage of Development 8

Table 2: Central Venous Catheters-Pipeline Products by Segment 9

Table 3: Central Venous Catheters-Pipeline Products by Territory 10

Table 4: Central Venous Catheters-Pipeline Products by Regulatory Path 11

Table 5: Central Venous Catheters-Pipeline Products by Estimated Approval Date 12

Table 6: Central Venous Catheters Companies-Pipeline Products by Stage of Development 13

Table 7: Central Venous Catheters-Pipeline Products by Stage of Development 14

Table 8: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 9: BaxCath Impregnation System-Product Status 15

Table 10: BaxCath Impregnation System-Product Description 15

Table 11: Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 16

Table 12: Transvascular Injection Catheter-Product Status 16

Table 13: Transvascular Injection Catheter-Product Description 16

Table 14: Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: Central Venous Permanent Catheter-Product Status 17

Table 16: Central Venous Permanent Catheter-Product Description 17

Table 17: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: Safety IV Catheter-Product Status 18

Table 19: Safety IV Catheter-Product Description 18

Table 20: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 19

Table 21: Infusense System-Product Status 19

Table 22: Infusense System-Product Description 19

Table 23: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Table 24: NexSite 8Fr Single Lumen Central Venous Catheter-Product Status 20

Table 25: NexSite 8Fr Single Lumen Central Venous Catheter-Product Description 20

Table 26: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 21

Table 27: Biocompatible Intravenous Catheter-Product Status 21

Table 28: Biocompatible Intravenous Catheter-Product Description 21

Table 29: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Table 30: NextCath-Product Status 22

Table 31: NextCath-Product Description 22

Table 32: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

Table 33: Safety IV Catheter-Product Status 23

Table 34: Safety IV Catheter-Product Description 23

Table 35: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 24

Table 36: 3V AGILE-Product Status 24

Table 37: 3V AGILE-Product Description 24

Table 38: Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 39: Sharklet Central Venous Catheter-Product Status 25

Table 40: Sharklet Central Venous Catheter-Product Description 25

Table 41: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 26

Table 42: Umbilical Artery Catheter-Product Status 26

Table 43: Umbilical Artery Catheter-Product Description 26

Table 44: Umbilical Vein Catheter-Product Status 27

Table 45: Umbilical Vein Catheter-Product Description 27

Table 46: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 47: Cathanic Venous Catheter-Product Status 28

Table 48: Cathanic Venous Catheter-Product Description 28

Table 49: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29

Table 50: ARROW JACC Nurse Insertion CVC System-Product Status 29

Table 51: ARROW JACC Nurse Insertion CVC System-Product Description 29

Table 52: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 30

Table 53: Extendable Intravenous Catheter-Product Status 30

Table 54: Extendable Intravenous Catheter-Product Description 30

Table 55: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 31

Table 56: WIN NIC Central Venous Catheter Introducer Kit-Product Status 31

Table 57: WIN NIC Central Venous Catheter Introducer Kit-Product Description 31

Table 58: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 32

Table 59: Anti-Thrombotic And Anti-Infective Central Venous Catheter-Product Status 32

Table 60: Anti-Thrombotic And Anti-Infective Central Venous Catheter-Product Description 32

Table 61: Glossary 81

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Ash Access Technology Inc

Bactiguard Holding AB

Charite University Hospital of Berlin

Globe Medical Tech Inc

Infusense Corp

Marvao Medical Devices Ltd

Nipro Corp

Pavmed Inc

Protectus Medical Devices, Inc.

S3V Vascular Technologies

Sharklet Technologies Inc

Silmag SA

Silver Bullet Therapeutics, Inc.

Teleflex Inc

University of Illinois at Chicago

University of Utah

Vindica Therapeutics, Inc

Ash Access Technology Inc, BaxCath Impregnation System; Bactiguard Holding AB, Transvascular Injection Catheter; Charite University Hospital of Berlin, Central Venous Permanent Catheter; Globe Medical Tech Inc (Inactive), Safety IV Catheter; Infusense Corp, Infusense System; Marvao Medical Devices Ltd, NexSite 8Fr Single Lumen Central Venous Catheter; Nipro Corp, Biocompatible Intravenous Catheter; Pavmed Inc, NextCath; Protectus Medical Devices, Inc., Safety IV Catheter; S3V Vascular Technologies, 3V AGILE; Sharklet Technologies Inc, Sharklet Central Venous Catheter; Silmag SA, Umbilical Artery Catheter; Silmag SA, Umbilical Vein Catheter; Silver Bullet Therapeutics, Inc., Cathanic Venous Catheter; Teleflex Inc, ARROW JACC Nurse Insertion CVC System; University of Illinois at Chicago, Extendable Intravenous Catheter; University of Utah, WIN NIC Central Venous Catheter Introducer Kit; Vindica Therapeutics, Inc, Anti-Thrombotic And Anti-Infective Central Venous Catheter

select a license
Single User License
USD 2500 INR 177425
Site License
USD 5000 INR 354850
Corporate User License
USD 7500 INR 532275

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com